SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 21, 2005
PHARMOS CORPORATION
(Exact name of Registrant as Specified in its Charter)
Nevada
(States or Other Jurisdiction
of Incorporation) | 0-11550
(Commission file Number)
| 36-3207413
(IRS Employer
Identification No.)
|
99 Wood Avenue South, Suite 311, Iselin, NJ
(Address of Principal Executive Offices) | 08830
(Zip Code) |
Registrants’ telephone number, including area code (732) 452-9556
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-2 under the Exchange Act (17 CFR 240.14a-2)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On June 21, 2005, Pharmos Corporation (the “Company”) received notice from The Nasdaq Stock Market, Inc. (“Nasdaq”) that the Company has regained compliance with Nasdaq Marketplace Rule 4310(c)(4). Such Rule, in general, requires that a listed company maintain a closing bid price of $1.00 for continued listing on the NASDAQ SmallCap Market. The notice stated that for 10 consecutive business days, the Company’s stock had closed above $1.00, and therefore, the Company regained compliance with this Rule. No further actions in this regard are required of the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 23rd day of June, 2005.
PHARMOS CORPORATION
Name: James A. Meer
Title: Senior Vice President, Chief Financial
Officer, Secretary and Treasurer
